LGALS3BP and Ewing sarcoma: For example, though high serum LGALS3BP levels are associated with poor clinical outcomes in patients with breast, hepatocellular, and non-small cell lung carcinoma16,46,47, high LGALS3BP expression in tumor tissues is associated with favorable outcomes in patients with Ewing’s sarcoma and CRC21,22.